Top compounds associated with response to BRSK1


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib GDSC1000 pan-cancer AAC -0.00069 1
mRNA tosedostat CTRPv2 pan-cancer AAC 0.11 0.007
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.057 0.1
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.1 0.001
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.12 0.004
mRNA triptolide CTRPv2 pan-cancer AAC -0.02 0.6
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.086 0.1
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.023 0.5
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.081 0.03
Download CSV